Delivery Order SPE2DB24D2011-SPE2DB25FBRVS
- Not listed
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count) with a contract value of $7,948.48. The order, designated as a firm fixed price delivery order with an ultimate completion date of August 13, 2025, was competitively awarded without set-aside provisions. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a...
- The U.S. Department of Defense's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Meloxicam 15 mg tablets in unit dose packaging (100 count), with a ceiling value of $1,838.08 and a firm fixed price structure. This delivery order was issued without a set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is the place of performance and serves as the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Meloxicam 15 mg tablets in a 90-count package, with a contract value of $2,000.95 and completion targeted for July 25, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at AmerisourceBergen's Conshohocken, Pennsylvania location. The contract represents a child order under AmerisourceBergen's larger...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $29,757.33 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Meloxicam 15 mg. The contract was competitively awarded without set-aside designation under a firm fixed-price delivery order structure, with an ultimate completion date of May 7, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,859.42 to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Meloxicam 15 mg. This firm fixed-price, non-competitive set-aside contract was executed on September 16, 2025, with an ultimate completion date of September 17, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in that same city....
- This is a firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of 15 mg meloxicam tablets. The contract has a ceiling value of $6,877.13 and a completion date of June 25, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support...
- The Defense Logistics Agency awarded a delivery order valued at $1,420.47 to AmerisourceBergen Drug Corp for 90 tablets of Meloxicam 15 mg, with a completion date of February 28, 2025. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and represents a continuation of the vendor's critical role in federal pharmaceutical procurement. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 15 mg meloxicam tablets. The contract has a ceiling value of $1,341.52 and a period of performance running through June 4, 2025. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global pharmaceutical support...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,563,867,341 units of Meloxicam 15 mg tablets in 180-count bottles, with a ceiling value of $28,109.04. The contract is a Firm Fixed Price Delivery Order with a period of performance through March 6, 2024. This contract is not designated as a set-aside....
- The Defense Logistics Agency awarded a $203,000 delivery order contract to Amerisourcebergen Drug Corporation to supply 1,000 tablets of 7.5 mg meloxicam. The contract has a firm fixed price and performance will take place in Conshohocken, Pennsylvania over a three-day period in early September 2023. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will serve as the prime contractor to fulfill this order for the analgesic medication in support of Defense Logistics...
- SPE2DB24D2011Indefinite Delivery Contract
- SPE2DB24D2011-SPE2DB25FBRVSDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Meloxicam 15 mg tablet units (100 count) valued at $1,149.80 on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. Meloxicam is a nonsteroidal anti-inflammatory drug commonly used in military and federal healthcare systems for pain management and anti-inflammatory treatment. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive global pharmaceutical support vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard. The contract represents a critical component of the federal pharmaceutical supply chain supporting defense and veteran healthcare operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 9/15/25 |